Granules India spurts on getting nod for scheme of arrangement

21 Feb 2014 Evaluate

Granules India is currently trading at Rs. 280.40, up by 5.70 points or 2.07 % from its previous closing of Rs. 274.70 on the BSE.

The scrip opened at Rs. 276.00 and has touched a high and low of Rs. 283.70 and Rs. 276.00 respectively. So far 47756 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 294.00 on 12-Feb-2014 and a 52 week low of Rs. 90.15 on 22-Mar-2013.

Last one week high and low of the scrip stood at Rs. 280.75 and Rs. 262.00 respectively. The current market cap of the company is Rs. 566.25 crore.

The promoters holding in the company stood at 48.86 % while Institutions and Non-Institutions held 1.62 % and 49.42 % respectively.

Granules India’s board of directors at its meeting held on February 20, 2014 has approved the Scheme of Arrangement involving amalgamation of Auctus Pharma with Granules India.

Granules India is a fast growing pharmaceutical manufacturing company with world class facilities and is committed to manufacturing excellence, quality and customer service. The Company produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) for quality conscious customers in the regulated and semi-regulated markets.

Granules India Share Price

558.90 13.45 (2.47%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.